Assenagon Asset Management S.A. Buys 12,983 Shares of Humana Inc. $HUM

Assenagon Asset Management S.A. raised its position in shares of Humana Inc. (NYSE:HUM) by 248.3% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 18,212 shares of the insurance provider’s stock after purchasing an additional 12,983 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Humana were worth $4,665,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in HUM. Rosenberg Matthew Hamilton increased its position in shares of Humana by 136.0% during the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after buying an additional 68 shares during the period. Elevation Point Wealth Partners LLC acquired a new position in Humana in the second quarter valued at $32,000. Mather Group LLC. bought a new stake in Humana during the third quarter valued at $34,000. Private Wealth Management Group LLC grew its holdings in Humana by 47.5% during the 3rd quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after acquiring an additional 48 shares during the period. Finally, Larson Financial Group LLC grew its holdings in Humana by 114.1% during the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock worth $40,000 after acquiring an additional 81 shares during the period. Institutional investors own 92.38% of the company’s stock.

Insider Activity

In other Humana news, insider Sanjay K. Shetty acquired 810 shares of Humana stock in a transaction dated Monday, February 23rd. The stock was purchased at an average cost of $185.21 per share, for a total transaction of $150,020.10. Following the completion of the acquisition, the insider directly owned 11,657 shares of the company’s stock, valued at $2,158,992.97. This represents a 7.47% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.20% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the company. JPMorgan Chase & Co. dropped their price objective on Humana from $274.00 to $180.00 and set a “neutral” rating on the stock in a research note on Friday, February 13th. Cantor Fitzgerald lowered their target price on Humana from $290.00 to $201.00 and set a “neutral” rating for the company in a report on Thursday, February 12th. Zacks Research raised Humana from a “strong sell” rating to a “hold” rating in a research note on Thursday, March 5th. The Goldman Sachs Group cut their price target on Humana from $215.00 to $158.00 and set a “sell” rating on the stock in a report on Friday, February 13th. Finally, Royal Bank Of Canada downgraded shares of Humana from an “outperform” rating to a “sector perform” rating and reduced their price objective for the stock from $322.00 to $189.00 in a research report on Thursday, February 12th. Seven research analysts have rated the stock with a Buy rating, sixteen have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $225.48.

Humana Stock Down 0.0%

HUM stock opened at $169.06 on Monday. The stock’s 50 day simple moving average is $191.71 and its 200 day simple moving average is $238.40. The company has a market cap of $20.30 billion, a P/E ratio of 17.22, a price-to-earnings-growth ratio of 1.81 and a beta of 0.44. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.00 and a current ratio of 2.00. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $315.35.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, February 11th. The insurance provider reported ($3.96) EPS for the quarter, beating analysts’ consensus estimates of ($4.01) by $0.05. Humana had a return on equity of 11.43% and a net margin of 0.92%.The firm had revenue of $32.64 billion during the quarter, compared to analysts’ expectations of $32.08 billion. During the same quarter last year, the firm posted ($2.16) earnings per share. The company’s revenue for the quarter was up 11.3% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. On average, research analysts expect that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend is Friday, March 27th. Humana’s dividend payout ratio (DPR) is 36.05%.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.